LAUSANNE, Switzerland -- The International Gymnastics Federation made no decision Saturday on the U.S. Anti-Doping Agency's punishment concerning gymnast Morgan Hamm.
USA Gymnastics president Steve Penny said he expected an announcement on Monday.
USA Gymnastics and the U.S. Olympic Committee had already said that the warning would not affect Hamm's spot on the team for the Beijing Games.
USADA announced July 3 that Hamm had been warned for a May 24 positive test for glucocorticosteroid, a cortisone-like anti-inflammatory. The drug is allowed if an athlete gets a therapeutic use exemption, but Hamm had failed to do that.
Hamm said he got the shot May 2 from his doctor after taping, ultrasound and other therapies failed to reduce the pain and swelling in his left ankle. After being notified of the positive test, which occurred the second day of the national championships, he sent USADA his medical records and letters from his doctor and physical therapist. USADA said it had "absolutely no concern" the shot was for anything but medicinal purposes.
As part of his punishment, Hamm's results from the second day of nationals were wiped out. But USAG and the USOC reviewed all of the results from nationals and the Olympic trials, and said Hamm would still have made the team.
Because international federations have the right to appeal USADA decisions to the Court of Arbitration for Sport, however, the FIG's disciplinary commission had to follow protocol and review the case.
USADA and USA Gymnastics sent representatives to the commission's regularly scheduled meeting at FIG headquarters in case there were any questions. Hamm did not attend, though he did give the commission a statement explaining what happened.